Holen Sie sich die Stockscreener-App
654.04
0.17%
1.13
Handel nachbörslich:
649.52
-4.52
-0.69%
Finanzdaten der Regeneron Pharmaceuticals Inc-Aktie (REGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
21.36%
3,675.60
|
3,028.70 | 3,789.20 | 3,720.70 | 3,547.10 |
Operating Expenses
|
6.53%
2,596.10
|
2,437.00 | 2,799.00 | 2,541.20 | 2,477.50 |
| Benefits Costs and Expenses |
1.56%
2,156.90
|
2,123.70 | 2,831.10 | 2,227.70 | 1,919.00 |
| Costs And Expenses |
6.53%
2,596.10
|
2,437.00 | 2,799.00 | 2,541.20 | 2,477.50 |
| Operating Income/Loss |
82.44%
1,079.50
|
591.70 | 990.20 | 1,179.50 | 1,069.60 |
| Nonoperating Income/Loss |
40.19%
439.20
|
313.30 | -32.10 | 313.50 | 558.50 |
| Income/Loss From Continuing Operations Before Tax |
67.81%
1,518.70
|
905.00 | 958.10 | 1,493.00 | 1,628.10 |
| Income Tax Expense/Benefit |
31.98%
127.10
|
96.30 | 40.40 | 152.40 | 195.80 |
| Income/Loss From Continuing Operations After Tax |
72.08%
1,391.60
|
808.70 | 917.70 | 1,340.60 | 1,432.30 |
|
Net Income/Loss
|
72.08%
1,391.60
|
808.70 | 917.70 | 1,340.60 | 1,432.30 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.50%
105.10
|
106.70 | -0.10 | 108.10 | 108.10 |
| Diluted Average Shares |
2.34%
108.60
|
111.20 | -0.50 | 116.20 | 115.40 |
| Basic Earnings Per Share |
74.67%
13.24
|
7.58 | 8.54 | 12.40 | 13.25 |
| Diluted Earnings Per Share |
76.20%
12.81
|
7.27 | 8.11 | 11.54 | 12.41 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
6.65%
16.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):